ELEVANCE HEALTH INC (A58.DE) Stock Fundamental Analysis
Europe - FRA:A58 - US0367521038 - Common Stock
301.9 EUR
+15.4 (+5.38%)
Overall A58 gets a fundamental rating of 4 out of 10. We evaluated A58 against 32 industry peers in the Health Care Providers & Services industry. While A58 is still in line with the averages on profitability rating, there are concerns on its financial health. A58 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year A58 was profitable.
A58 had a positive operating cash flow in the past year.
In the past 5 years A58 has always been profitable.
In the past 5 years A58 always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.40%, A58 is doing good in the industry, outperforming 76.67% of the companies in the same industry.
A58 has a Return On Equity of 12.26%. This is in the better half of the industry: A58 outperforms 66.67% of its industry peers.
A58 has a Return On Invested Capital (5.90%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for A58 is in line with the industry average of 6.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROIC | 5.9% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
The Profit Margin of A58 (2.83%) is comparable to the rest of the industry.
A58's Profit Margin has declined in the last couple of years.
A58 has a Operating Margin (4.60%) which is comparable to the rest of the industry.
A58's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
A58 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
A58 has less shares outstanding than it did 1 year ago.
A58 has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, A58 has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of A58 is 5.70, which is a neutral value as it means it would take A58, 5.70 years of fcf income to pay off all of its debts.
A58 has a better Debt to FCF ratio (5.70) than 73.33% of its industry peers.
A58 has a Debt/Equity ratio of 0.65. This is a neutral value indicating A58 is somewhat dependend on debt financing.
The Debt to Equity ratio of A58 (0.65) is better than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | N/A |
ROIC/WACC0.69
WACC8.49%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The earnings per share for A58 have decreased by -6.64% in the last year.
A58 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
The Revenue has grown by 10.21% in the past year. This is quite good.
The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%13.23%
3.2 Future
A58 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.89% yearly.
A58 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.93% yearly.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y7.93%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.73 indicates a reasonable valuation of A58.
Compared to the rest of the industry, the Price/Earnings ratio of A58 indicates a rather cheap valuation: A58 is cheaper than 93.33% of the companies listed in the same industry.
A58's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.86.
The Price/Forward Earnings ratio is 11.23, which indicates a very decent valuation of A58.
Based on the Price/Forward Earnings ratio, A58 is valued a bit cheaper than 73.33% of the companies in the same industry.
A58's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.73 | ||
| Fwd PE | 11.23 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of A58 is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as A58.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.07 | ||
| EV/EBITDA | 9.92 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y-2.2%
EPS Next 3Y3%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.01%, A58 has a reasonable but not impressive dividend return.
A58's Dividend Yield is a higher than the industry average which is at 2.38.
Compared to an average S&P500 Dividend Yield of 2.44, A58 has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
5.2 History
On average, the dividend of A58 grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
A58 pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
The dividend of A58 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
FRA:A58 (10/3/2025, 7:00:00 PM)
301.9
+15.4 (+5.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap67.98B
Analysts76.43
Price Target318.55 (5.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
Yearly Dividend5.58
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)4
Avg Revenue beat(4)2.28%
Min Revenue beat(4)0.29%
Max Revenue beat(4)4.3%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)12
Avg Revenue beat(16)1.04%
PT rev (1m)-42.81%
PT rev (3m)-42.81%
EPS NQ rev (1m)-55.08%
EPS NQ rev (3m)-55.08%
EPS NY rev (1m)-29.13%
EPS NY rev (3m)-29.13%
Revenue NQ rev (1m)5.41%
Revenue NQ rev (3m)5.41%
Revenue NY rev (1m)5.26%
Revenue NY rev (3m)5.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.73 | ||
| Fwd PE | 11.23 | ||
| P/S | 0.42 | ||
| P/FCF | 15.07 | ||
| P/OCF | 12.45 | ||
| P/B | 1.82 | ||
| P/tB | 20.64 | ||
| EV/EBITDA | 9.92 |
EPS(TTM)28.14
EY9.32%
EPS(NY)26.87
Fwd EY8.9%
FCF(TTM)20.03
FCFY6.63%
OCF(TTM)24.26
OCFY8.03%
SpS716.26
BVpS165.47
TBVpS14.62
PEG (NY)N/A
PEG (5Y)0.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROCE | 7.72% | ||
| ROIC | 5.9% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 11.77% | ||
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A | ||
| FCFM | 2.8% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 75.47% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 98.73% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC8.49%
ROIC/WACC0.69
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%13.23%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y7.93%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%